Lynparza (olaparib) Disease area(s): Oncology Manufacturer(s): AstraZeneca/Merck 2024 Sales (USD): $4.98 billion Why it sold so well: AstraZenecas Lynparza delivered a strong sales performance in 2024, with product revenues reaching $3.67 billion, marking a 22% increase at constant exchange rates compared to the previous year
ISRN Pharmacol 2013;2013:147238
The sprout extract of Tuscan black cabbage, a type of kale, was found to be protective against a high-fat diet in rats, restoring antioxidant and phase II enzyme levels and lowering serum lipids (total cholesterol, triacylglycerides, non-esterified fatty acids) (Melega et al., 2013)
With increasing interest in high purity research peptides Australia-wide and reliable Aussie peptide pharmacy alternatives, Lipo-C continues gaining attention within metabolic and performance-focused research communities
Liraglutyd - przeciwwskazania Zasadniczo jedynym przeciwwskazaniem do stosowania liraglutydu jest nadwraliwo na substancj czynn lub na ktrkolwiek z substancji pomocniczych w przypadku leku zarejestrowanego w Polsce substancjami takimi s: dwuwodny fosforan disodowy, glikol propylenowy, fenol, kwas chlorowodorowy, wodorotlenek sodu, woda do wstrzykiwa
You can also get vitamin B-12 deficiency if you follow a vegan diet (meaning you dont eat any animal products, including meat, milk, cheese, and eggs) or you are a vegetarian who doesnt eat enough eggs or dairy products to meet your vitamin B-12 needs
